www.bic.lv
Our company


BIC Securities is a leading independent corporate finance advisory firm acting mainly in Russia, Ukraine and the Baltics

Through our network and contacts we are well positioned to execute domestic and cross border equity transactions, primarily mergers & acquisitions (M&A), in our core markets as well as in other countries of Europe and CIS


Core markets:
  • Russian Federation
  • Ukraine
  • Baltic States – Latvia, Lithuania and Estonia
  • Scandinavian Countries

 

Other markets (also through partners' network):
  • UK, Germany, France
  • Czech Republic, Slovakia, Poland, Hungary, Slovenia, Romania, Bulgaria, Serbia
  • Other selected Eastern European and CIS countries

What's new
BIC Securities advised Otravo in acquisition of Interneto Partneris, Lithuania-based Online Travel Company
18/10/2017
Otravo, one of the market leaders in the area of online travel in Northwest Europe is taking over Lithuania-based online travel company Interneto Partneris, allowing Otravo to expand its operations in the Baltic States...
Read more

BIC Securities advised Amber Beverage Group on acquiring a stake in Cellar Trends, a leading independent UK alcohol distributor
15/05/2017
Amber Beverage Group (ABG), the largest alcohol manufacturer and distributor in the Baltics and part of SPI global group, acquired a significant minority stake in Cellar Trends, allowing the Company to significantly increase its position on the UK market...
Read more

BIC Securities acted as exclusive financial adviser to Digitalas Ekonomikas Attistibas Centrs (DEAC), leading Baltic data center services provider in attracting investment from BPM Mezzanine Fund
05/10/2016
BPM Mezzanine Fund SICAV-SIF, SCA (BPM) has invested in the leading Baltic data center operator DEAC to support its growth...
Read more

BIC Securities sponsored Russian Pharmaceutical Forum held by Adam Smith Conferences, which took place in Saint Petersburg on May 17-18, 2016
18/05/2016
Russian Pharmaceutical Forum is the foremost gathering of top management of international and local pharmaceutical producers, distributors and retailers...
Read more

BIC Securities advised Russian pharmaceutical producer DIOD (MICEX:DIOD) on sale of Orvirem brand portfolio to Alvogen
01/01/2016
DIOD, Russian pharmaceutical producer has completed the transaction on sale of Orvirem product brand portfolio, including trademarks and other product related IP rights, to Alvogen, a leading international pharmaceutical company...
Read more

BIC Securities advised the leading Russian pharmaceutical company in the purchase of EU-based pharmaceutical manufacturing company
01/12/2015
BIC Securities has acted as exclusive financial adviser to the shareholders of leading Russian pharmaceutical company in connection with the purchase of EU-based pharmaceutical manufacturing company...
Read more

BIC Securities acted as exclusive financial adviser to Eco Baltia, the largest waste management operator in the Baltics, and its shareholders in selling a minority stake to European Bank for Reconstruction and Development (EBRD)
24/08/2015
The European Bank for Reconstruction and Development (EBRD) is acquiring a minority stake in Eco Baltia JSC, a leading provider of waste treatment in Latvia and the Baltic states...
Read more

BIC Securities sponsored 21th Russian Pharmaceutical Forum held by Adam Smith Conferences, which took place in Saint Petersburg on May 19-20, 2015
20/05/2015
Russian Pharmaceutical Forum is the foremost gathering of CEOs of international and local pharmaceutical producers, distributors and retailers...
Read more

BIC Securities acted as exclusive financial adviser to shareholders of VENBEST Group, leading Ukrainian private security services market operator, on sale of equity stake to regional private equity fund
14/05/2015
Europe Virgin Fund L.P. (‘EVF’), a regional private equity fund sponsored by Dragon Capital, has completed its investment in VENBEST Group, a leading private security services market operator in Ukraine...
Read more



Quick search



Copyright © 1999-2017 BIC Securities.
All rights reserved.